Summit Trail Advisors, LLC Myriad Genetics Inc Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $50,719 - $67,959	-1,350 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$27.75 - $40.17 $1.37 Million - $1.98 Million	-49,290 Reduced 97.33%	1,350 $50,000
Q1 2018 May 21, 2018	BUY	$28.83 - $41.01 $1.41 Million - $2 Million	48,800 Added 2652.17%	50,640 $51,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $52,348 - $68,337	1,840	1,840 $70,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.